ZA911330B - Vectors and compounds for expression of zymogen forms of human protein c - Google Patents

Vectors and compounds for expression of zymogen forms of human protein c

Info

Publication number
ZA911330B
ZA911330B ZA911330A ZA911330A ZA911330B ZA 911330 B ZA911330 B ZA 911330B ZA 911330 A ZA911330 A ZA 911330A ZA 911330 A ZA911330 A ZA 911330A ZA 911330 B ZA911330 B ZA 911330B
Authority
ZA
South Africa
Prior art keywords
vectors
expression
compounds
human protein
zymogen forms
Prior art date
Application number
ZA911330A
Other languages
English (en)
Inventor
Bruce Edward Gerlitz
Edward Gerlitz Bruce
Brian William Grinnell
William Grinnell Brian
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ZA911330B publication Critical patent/ZA911330B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6464—Protein C (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333—Saccharide [e.g., DNA, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
ZA911330A 1990-02-23 1991-02-22 Vectors and compounds for expression of zymogen forms of human protein c ZA911330B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/484,133 US5270178A (en) 1990-02-23 1990-02-23 Vectors and compounds for expression of zymogen forms of human protein C

Publications (1)

Publication Number Publication Date
ZA911330B true ZA911330B (en) 1992-10-28

Family

ID=23922892

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA911330A ZA911330B (en) 1990-02-23 1991-02-22 Vectors and compounds for expression of zymogen forms of human protein c

Country Status (17)

Country Link
US (1) US5270178A (hu)
EP (1) EP0443875A3 (hu)
JP (1) JPH05103678A (hu)
KR (1) KR910021476A (hu)
CN (1) CN1054798A (hu)
AU (1) AU7130891A (hu)
CA (1) CA2036915A1 (hu)
FI (1) FI910853A (hu)
HU (1) HUT61592A (hu)
IE (1) IE910610A1 (hu)
IL (1) IL97310A0 (hu)
MX (1) MX24652A (hu)
NO (1) NO910720L (hu)
NZ (1) NZ237198A (hu)
PT (1) PT96854A (hu)
YU (1) YU31791A (hu)
ZA (1) ZA911330B (hu)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL97312A (en) * 1990-02-23 1999-01-26 Lilly Co Eli A method of generating a polypeptide in an eukaryotic vector AND recombinant surrogate cell containing an enhanced transcriptional control unit based on the primary late adenovirus coefficient
IL97311A0 (en) * 1990-02-23 1992-05-25 Lilly Co Eli Vectors and compounds for expression of glycosylation mutants of human protein c
MY110664A (en) * 1992-05-21 1999-01-30 Lilly Co Eli Protein c derivatives
DE4320294A1 (de) * 1993-06-18 1994-12-22 Immuno Ag Verwendung von humanem Protein C zur Verhinderung und Behandlung von Thrombozytenablagerungen
US5585095A (en) * 1993-09-14 1996-12-17 Regents Of The University Of Minnesota Method to enhance thrombomodulin APC generation using cationic proteins
AU1477000A (en) * 1998-11-13 2000-06-05 Eli Lilly And Company Method of treating heparin-induced thrombocytopenia
US6998122B1 (en) * 1999-04-30 2006-02-14 Eli Lilly And Company Protein C derivatives
US6420157B1 (en) * 1999-04-30 2002-07-16 Ortho-Mcneil Pharmaceutical, Inc. Zymogen activation system
US6485957B1 (en) 1999-04-30 2002-11-26 Ortho-Mcneil Pharmaceutical, Inc. DNA encoding the human serine protease EOS
US6426199B1 (en) 1999-08-31 2002-07-30 Ortho-Mcneil Pharmaceutical, Inc. Dna
US6458564B1 (en) 1999-08-31 2002-10-01 Ortho-Mcneil Pharmaceutical, Inc. DNA encoding the human serine protease T
AU1751801A (en) * 1999-11-19 2001-05-30 Eli Lilly And Company Protein c derivatives
EP1255821B1 (en) 2000-02-02 2004-12-29 Eli Lilly And Company Protein c derivatives
AU2001232799A1 (en) 2000-02-11 2001-08-20 Eli Lilly And Company Protein c derivatives
US6933367B2 (en) * 2000-10-18 2005-08-23 Maxygen Aps Protein C or activated protein C-like molecules
KR20030060915A (ko) * 2000-10-18 2003-07-16 맥시겐 에이피에스 단백질 씨 또는 활성 단백질 씨-유사 분자
US20070142272A1 (en) * 2003-01-24 2007-06-21 Zlokovic Berislav V Neuroprotective activity of activated protein c independent of its anticoagulant activity
JP2008507561A (ja) * 2004-07-23 2008-03-13 ザ ユニバーシティ オブ ロチェスター 活性化プロテインｃによる、脳内のプラスミノゲン活性化因子の不都合な作用の阻害
CA2654761A1 (en) * 2006-06-09 2007-12-13 The University Of British Columbia Interferon gamma polymorphisms as indicators of subject outcome in critically ill subjects
WO2009089620A1 (en) * 2008-01-15 2009-07-23 The Universityof British Columbia Protein c rs2069915 as a response predictor to survival and administration of activated protein c or protein c-like compound
WO2012068519A2 (en) 2010-11-19 2012-05-24 Sirius Genomics Inc. Markers associated with response to activated protein c administration, and uses thereof
WO2023119230A1 (en) 2021-12-22 2023-06-29 L'oreal Coagulation pathway and nicotinamide-adenine dinucleotide pathway modulating compositions and methods of their use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4775624A (en) * 1985-02-08 1988-10-04 Eli Lilly And Company Vectors and compounds for expression of human protein C
EP0215548B2 (en) * 1985-06-27 1998-01-07 Zymogenetics, Inc. Expression of protein C
EP0245949B1 (en) * 1986-04-09 1997-10-29 Eli Lilly And Company A method of using eukaryotic expression vectors comprising the bk virus enhancer
US4992373A (en) * 1987-12-04 1991-02-12 Eli Lilly And Company Vectors and compounds for direct expression of activated human protein C
ZA889497B (en) * 1987-12-28 1990-08-29 Lilly Co Eli Vectors and compounds for expression of zymogen forms of human protein c
CA1332049C (en) * 1988-10-07 1994-09-20 Eli Lilly And Company Eukaryotic expression

Also Published As

Publication number Publication date
HU910605D0 (en) 1991-09-30
NZ237198A (en) 1993-07-27
KR910021476A (ko) 1991-12-20
AU7130891A (en) 1991-08-29
NO910720L (no) 1991-08-26
CA2036915A1 (en) 1991-08-24
MX24652A (es) 1994-01-31
CN1054798A (zh) 1991-09-25
HUT61592A (en) 1993-01-28
NO910720D0 (no) 1991-02-22
IE910610A1 (en) 1991-08-28
JPH05103678A (ja) 1993-04-27
FI910853A0 (fi) 1991-02-22
EP0443875A3 (en) 1992-07-15
YU31791A (sh) 1994-05-10
EP0443875A2 (en) 1991-08-28
PT96854A (pt) 1991-10-31
US5270178A (en) 1993-12-14
FI910853A (fi) 1991-08-24
IL97310A0 (en) 1992-05-25

Similar Documents

Publication Publication Date Title
KR970009081B1 (en) Vectors and compounds for direct expression of activated human protein c
EP0443875A3 (en) Vectors and compounds for expression of zymogen forms of human protein c
HU9301510D0 (en) Inhibition of interaction of protein causing cell adhession and carbonhydrate
EP0450598A3 (en) Inhibitors of the advanced glycosylation of proteins and methods of use therefor
PL289846A1 (en) Method of obtaining lyposome preparations containing peptides
AR244804A1 (es) Secuencia de dna que codifica una forma zimogena de la proteina c humana, vector de expresion, celulas eucarioticas transformadas y metodo para formas zimogenas de dicha proteina c.
EP0472422A3 (en) Oligohexafluoropropylene compounds and methods of making them
HUP9800829A3 (en) Collagen-based methods and formulations for the treatment of immune system-mediated diseases
EP0454485A3 (en) Expression of insecticidal proteins
SG49230A1 (en) Vectors expressing of human interferon for the treatment of AIDS
IL96688A0 (en) Expression of delta-endotoxin proteins
HU910604D0 (en) Vectors and compounds for expressing glycosyled derivatives of human c protein
HU911530D0 (en) Vectors and compounds for expression of glycosyled derivatives of human c protein
EP0540575A4 (en) Human meg-csf protein and methods
EP0459788A3 (en) Modified proteins and methods of producing same
ZA927468B (en) Novel activities of MK protein
EP0562624A3 (en) Stabilization of functional proteins
CS29390A2 (en) Method of hormonal preparations' biological activity determination
GB8324953D0 (en) Preparations for treatment of skin and hair
SG50520A1 (en) Protein curuculin and application of the same
GB9217258D0 (en) Testing of animal tissue
GB8707293D0 (en) Preventing inactivation of g proteins
GB9025320D0 (en) N-terminal modification of proteins
ZA916552B (en) Human mk gene and protein sequence
ZA934714B (en) Medical use of enzymes